论文部分内容阅读
ＨＯＰＥ(ＨｅａｒｔＯｕｔｃｏｍｅｓＰｒｅｖｅｎｔｉｏｎＥｖａｌｕａｔｉｏｎ)研究已表明 ,血管紧张素转换酶抑制剂雷米普利(ｒａｍｉｐｒｉｌ)对心血管事件和疾病进程具有有益的治疗效果1。在本期杂志中研究者们报告了该药在预防脑卒中方面的结果 (见本期 183页 ) 2 。研
HOPE (Heart Outcomes Prevention Evaluation) studies have shown that the angiotensin converting enzyme inhibitor ramipril has a beneficial therapeutic effect on cardiovascular events and disease progression1. In this issue of the journal, researchers report the drug’s results in stroke prevention (see page 183 of this issue). research